ethyl-alpha-guanido-methyl ethanoate
Small moleculeexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
1
Earliest trial started Feb 1, 2010 (NCT00988988)
Timeline
No events for the selected filters.
Indications
Approved for
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ethyl-alpha-guanido-methyl ethanoate
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00988988 | Phase 4 | Feb 1, 2010 | Teva, University of Nebraska |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Teva | For profit | 1 | 0 | 1 | 2010 |
| University of Nebraska | Academic/Hospital | 1 | 1 | 1 | 2010 |
2 organizations
Page 1 / 1